"Longer follow-ups after the pandemic are needed to investigate persistent brain aging effects and their long-term ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...

Co-authors reported grants from Takeda Pharmaceuticals and UCB, consulting for GlaxoSmithKline, and personal fees from the ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

Looking for more energy supply, the university opted to build the system in Montgomery County, 30 miles from the main campus.

Key earnings expected from PSU and private sector leaders. Watch for market cues from Bharat Electronics Ltd, Adani Green ...

Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...

U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for children.

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...